335 related articles for article (PubMed ID: 11489299)
1. Effect of intracerebral 6-nitronoradrenaline, an endogenous catechol-O-methyltransferase (COMT) inhibitor, on striatal dopamine metabolism in anaesthetised rats.
Huotari M; Passlin M; Nordberg HL; Forsberg M; Kotisaari S; Tuomisto L; Shintani F; Tanaka KF; Reenilä I; Laitinen K; Männistö PT
J Neurosci Methods; 2001 Aug; 109(1):47-52. PubMed ID: 11489299
[TBL] [Abstract][Full Text] [Related]
2. Effects of tolcapone, a novel catechol-O-methyltransferase inhibitor, on striatal metabolism of L-dopa and dopamine in rats.
Napolitano A; Zürcher G; Da Prada M
Eur J Pharmacol; 1995 Feb; 273(3):215-21. PubMed ID: 7737328
[TBL] [Abstract][Full Text] [Related]
3. Effects of peripheral and central catechol-O-methyltransferase inhibition on striatal extracellular levels of dopamine: a microdialysis study in freely moving rats.
Napolitano A; Bellini G; Borroni E; Zürcher G; Bonuccelli U
Parkinsonism Relat Disord; 2003 Jan; 9(3):145-50. PubMed ID: 12573869
[TBL] [Abstract][Full Text] [Related]
4. [Microdialysis study of tolcapone effect during blockage of neuronal dopamine reuptake caused by GBR-12909].
Budygin EA; Gaĭnetdinov RR; Raevskiĭ KS; Li IH; Mannisto PT
Eksp Klin Farmakol; 1997; 60(5):8-10. PubMed ID: 9483396
[TBL] [Abstract][Full Text] [Related]
5. Microdialysis studies on the action of tolcapone on pharmacologically-elevated extracellular dopamine levels in conscious rats.
Huotari M; Gainetdinov R; Männistö PT
Pharmacol Toxicol; 1999 Nov; 85(5):233-8. PubMed ID: 10608486
[TBL] [Abstract][Full Text] [Related]
6. Minor effect of tolcapone, a catechol-O-methyltransferase inhibitor, on extracellular dopamine levels modified by amphetamine or pargyline: a microdialysis study in anaesthetized rats.
Tuomainen P; Törnwall M; Männistö PT
Pharmacol Toxicol; 1996 Jun; 78(6):392-6. PubMed ID: 8829199
[TBL] [Abstract][Full Text] [Related]
7. Modulation of rat brain endogenous dopamine metabolism by new inhibitors of catechol O-methyltransferase.
Törnwall M; Tuomainen P; Männistö PT
Eur J Pharmacol; 1993 Aug; 239(1-3):39-45. PubMed ID: 8223912
[TBL] [Abstract][Full Text] [Related]
8. No change of brain extracellular catecholamine levels after acute catechol-O-methyltransferase inhibition: a microdialysis study in anaesthetized rats.
Li YH; Wirth T; Huotari M; Laitinen K; MacDonald E; Männistö PT
Eur J Pharmacol; 1998 Sep; 356(2-3):127-37. PubMed ID: 9774242
[TBL] [Abstract][Full Text] [Related]
9. Dopaminergic transmission in the rat striatum in vivo in conditions of pharmacological modulation.
Raevskii KS; Gainetdinov RR; Budygin EA; Mannisto P; Wightman M
Neurosci Behav Physiol; 2002; 32(2):183-8. PubMed ID: 11942697
[TBL] [Abstract][Full Text] [Related]
10. Microdialysis with radiometric monitoring of L-[β-11C]DOPA to assess dopaminergic metabolism: effect of inhibitors of L-amino acid decarboxylase, monoamine oxidase, and catechol-O-methyltransferase on rat striatal dialysate.
Okada M; Nakao R; Hosoi R; Zhang MR; Fukumura T; Suzuki K; Inoue O
J Cereb Blood Flow Metab; 2011 Jan; 31(1):124-31. PubMed ID: 20407462
[TBL] [Abstract][Full Text] [Related]
11. The central catechol-O-methyltransferase inhibitor tolcapone increases striatal hydroxyl radical production in L-DOPA/carbidopa treated rats.
Gerlach M; Xiao AY; Kuhn W; Lehnfeld R; Waldmeier P; Sontag KH; Riederer P
J Neural Transm (Vienna); 2001; 108(2):189-204. PubMed ID: 11314772
[TBL] [Abstract][Full Text] [Related]
12. Modulation of hippocampal dopamine metabolism and hippocampal-dependent cognitive function by catechol-O-methyltransferase inhibition.
Laatikainen LM; Sharp T; Bannerman DM; Harrison PJ; Tunbridge EM
J Psychopharmacol; 2012 Dec; 26(12):1561-8. PubMed ID: 22815336
[TBL] [Abstract][Full Text] [Related]
13. Catechol-O-methyltransferase inhibition increases striatal L-dopa and dopamine: an in vivo study in rats.
Brannan T; Martínez-Tica J; Yahr MD
Neurology; 1992 Mar; 42(3 Pt 1):683-5. PubMed ID: 1549240
[TBL] [Abstract][Full Text] [Related]
14. Effects of COMT inhibitors on striatal dopamine metabolism: a microdialysis study.
Kaakkola S; Wurtman RJ
Brain Res; 1992 Aug; 587(2):241-9. PubMed ID: 1381981
[TBL] [Abstract][Full Text] [Related]
15. Effect of tolcapone, a catechol-O-methyltransferase inhibitor, on striatal dopaminergic transmission during blockade of dopamine uptake.
Budygin EA; Gainetdinov RR; Kilpatrick MR; Rayevsky KS; Männistö PT; Wightman RM
Eur J Pharmacol; 1999 Apr; 370(2):125-31. PubMed ID: 10323260
[TBL] [Abstract][Full Text] [Related]
16. The role of physicochemical properties of entacapone and tolcapone on their efficacy during local intrastriatal administration.
Forsberg MM; Huotari M; Savolainen J; Männistö PT
Eur J Pharm Sci; 2005 Apr; 24(5):503-11. PubMed ID: 15784340
[TBL] [Abstract][Full Text] [Related]
17. Comparison of two new inhibitors of catechol O-methylation on striatal dopamine metabolism: a microdialysis study in rats.
Törnwall M; Kaakkola S; Tuomainen P; Kask A; Männistö PT
Br J Pharmacol; 1994 May; 112(1):13-8. PubMed ID: 7518301
[TBL] [Abstract][Full Text] [Related]
18. Sexually dimorphic effects of catechol-O-methyltransferase (COMT) inhibition on dopamine metabolism in multiple brain regions.
Laatikainen LM; Sharp T; Harrison PJ; Tunbridge EM
PLoS One; 2013; 8(4):e61839. PubMed ID: 23613951
[TBL] [Abstract][Full Text] [Related]
19. Different in vivo properties of three new inhibitors of catechol O-methyltransferase in the rat.
Männistö PT; Tuomainen P; Tuominen RK
Br J Pharmacol; 1992 Mar; 105(3):569-74. PubMed ID: 1628144
[TBL] [Abstract][Full Text] [Related]
20. [Pharmacological modulation of dopaminergic transmission in the rat striatum in vivo].
Raevskiĭ KS; Gaĭnetdinov RR; Budygin EA; Mannisto P; Wightman M
Ross Fiziol Zh Im I M Sechenova; 2000 Sep; 86(9):1152-9. PubMed ID: 11081220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
